NCT04115189 - A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 13, 2019

Primary Completion Date

December 2, 2020

Study Completion Date

December 2, 2020

Conditions

Metastatic Renal Cell Carcinoma ( mRCC)

Interventions

DRUG

Sunitinib

Patients to receive Sunitinib as first line therapy for mRCC

Trial Locations (7)

Instituto Médico Especializado Alexander Fleming, Buenos Aires

Sanatorio del Salvador - Cordoba, Córdoba

Escola Paulista de Medicina - UNIFESP, São Paulo

Fundacion Cardiovascular de Colombia, Bogotá

Sociedad de Oncologia y Hematologia Del Cesar ltda (SOHEC), Valledupar

Hospital Eugenio Espejo, Quito

Centro Oncológico de Integración Regional in Mendoza, Mendoza